Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)

Johnson & Johnson's Share-based Compensation history runs 18 years deep, the most recent figure standing at $300.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 4.17% year-over-year to $300.0 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 17.56% YoY), while the FY2025 annual figure was $1.4 billion, up 15.14% from the prior year.
• Share-based Compensation came in at $300.0 million for Q1 2026 at Johnson & Johnson, down from $309.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $410.0 million in Q2 2025 to a low of $178.0 million in Q4 2023.
• A 5-year average of $299.2 million and a median of $300.0 million in 2026 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation dropped 18.35% in 2023 and soared 33.71% in 2024, its largest moves.
• Johnson & Johnson's Share-based Compensation stood at $278.0 million in 2022, then sank by 35.97% to $178.0 million in 2023, then surged by 33.71% to $238.0 million in 2024, then rose by 29.83% to $309.0 million in 2025, then dropped by 2.91% to $300.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $300.0 million, $309.0 million, and $347.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison